Australian shares are poised to surge 2% at the open, buoyed by global bets on progress toward a vaccine against the COVID-19 virus. In late trade in New York, the Dow was up more than 900 points.
Drug maker Moderna said its experimental COVID-19 vaccine showed promising results in a small early-stage trial.
Loading...
Timothy Moore writes on equities, commodities and monetary policy. He writes Before the Bell and contributes to the Markets Live blog. Connect with Timothy on Twitter. Email Timothy at timothy.moore@afr.com
